Literature DB >> 15782923

The psychological and social burdens of psoriasis.

Melodie Young1.   

Abstract

Psoriasis imposes psychological and social burdens on sufferers, in addition to the physical toll. A recent survey of 502 people with moderate-to-severe psoriasis discovered that 38% of patients with psoriasis experience disease-related disruption in day-to-day activity, including work, school, interpersonal relationships, recreational activities, and intimacy. Discrimination, lack of self-confidence, and feelings of isolation, anger, and hopelessness are also quite common. In addition, another survey of 1000 adult Americans without psoriasis was conducted to determine the awareness of psoriasis by the general public. This survey confirmed a low level of awareness and understanding of the disease among people without psoriasis, suggesting that a lack of sensitivity may contribute to the social burdens of suferers.

Entities:  

Mesh:

Year:  2005        PMID: 15782923

Source DB:  PubMed          Journal:  Dermatol Nurs        ISSN: 1060-3441


  7 in total

1.  An Analysis of Patient-reported Outcomes in IXORA-S: Comparing Ixekizumab and Ustekinumab over 52 Weeks in Moderate-to-severe Psoriasis.

Authors:  Lluís Puig; Mark Lomaga; Kristin Hollister; Yves Dutronc; Lovisa Berggren; Peter C M van de Kerkhof
Journal:  Acta Derm Venereol       Date:  2020-12-09       Impact factor: 3.875

2.  The Level of Stigmatization and Depression of Patients with Psoriasis.

Authors:  Barbara Jankowiak; Beata Kowalewska; Dzmitry Fiodaravich Khvorik; Elżbieta Krajewska-Kułak; Wiaczesław Niczyporuk
Journal:  Iran J Public Health       Date:  2016-05       Impact factor: 1.429

3.  How does stigma affect people with psoriasis?

Authors:  Patryk Łakuta; Kamil Marcinkiewicz; Beata Bergler-Czop; Ligia Brzezińska-Wcisło
Journal:  Postepy Dermatol Alergol       Date:  2017-02-07       Impact factor: 1.837

4.  The Sense of Stigmatization in Patients with Plaque Psoriasis.

Authors:  Barbara Jankowiak; Beata Kowalewska; Elżbieta Krajewska-Kułak; Krystyna Kowalczuk; Dzmitry F Khvorik
Journal:  Dermatology       Date:  2020-08-25       Impact factor: 5.366

5.  Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study.

Authors:  A Bewley; D M Burrage; S J Ersser; M Hansen; C Ward
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-05-13       Impact factor: 6.166

6.  Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.

Authors:  Lakshi M Aldredge; Melodie S Young
Journal:  J Dermatol Nurses Assoc       Date:  2016-02-12

7.  Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.

Authors:  Leon Kircik; Joseph Fowler; Jonathan Weiss; Xiangyi Meng; Adriana Guana; Judit Nyirady
Journal:  Dermatol Ther (Heidelb)       Date:  2016-08-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.